Summary
A video showing a California mom's skin condition improvement went viral after she joined a clinical trial. The trial tests a medication called Ritlecitinib for treating vitiligo, a condition that causes skin pigment loss. The trial's progress has been shared online, gaining significant attention.
Key Facts
- Reshma Vincent, a mother from California, has vitiligo, which causes white patches on the skin.
- She joined a clinical trial testing the medication Ritlecitinib for vitiligo.
- The trial involves stopping other treatments and using either the medication or a placebo.
- The trial duration ranges from 14 to 26 months with regular check-ins.
- Vincent shared her progress on Instagram, gaining nearly 7 million views on a video.
- Vitiligo affects about 1 percent of the U.S. population, roughly 2.8 million people.
- Ritlecitinib has shown promising results in earlier safety trials.
- Vincent hopes the trial will provide hope to others with the condition.
